Detalhe da pesquisa
1.
A benzenesulfonamide derivative as a novel PET radioligand for CXCR4.
Bioorg Med Chem
; 28(2): 115240, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31843463
2.
Synthesis and evaluation of 2,5-diamino and 2,5-dianilinomethyl pyridine analogues as potential CXCR4 antagonists.
Bioorg Med Chem Lett
; 29(2): 220-224, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30514601
3.
Synthesis and evaluation of 2,5 and 2,6 pyridine-based CXCR4 inhibitors.
Bioorg Med Chem
; 24(21): 5052-5060, 2016 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27576294
4.
Early prediction of response to Vorinostat in an orthotopic rat glioma model.
NMR Biomed
; 25(9): 1104-11, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22302519
5.
Discovery of novel aminopiperidinyl amide CXCR4 modulators through virtual screening and rational drug design.
Eur J Med Chem
; 201: 112479, 2020 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32534343
6.
Amide-sulfamide modulators as effective anti-tumor metastatic agents targeting CXCR4/CXCL12 axis.
Eur J Med Chem
; 185: 111823, 2020 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31698158
7.
CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models.
Cancer Res
; 67(15): 7518-24, 2007 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17671223
8.
Synthesis and evaluation of 2,5-furan, 2,5-thiophene and 3,4-thiophene-based derivatives as CXCR4 inhibitors.
Eur J Med Chem
; 181: 111562, 2019 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31377592
9.
Development of CXCR4 modulators based on the lead compound RB-108.
Eur J Med Chem
; 173: 32-43, 2019 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30981691
10.
Assessing Treatment Response of Glioblastoma to an HDAC Inhibitor Using Whole-Brain Spectroscopic MRI.
Tomography
; 5(1): 53-60, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30854442
11.
Corrigendum to "Synthesis and evaluation of 2,5-furan, 2,5-thiophene and 3,4-thiophene-based derivatives as CXCR4 inhibitors" [Eur. J. Med. Chem. 181 (2019) 111562].
Eur J Med Chem
; 261: 115753, 2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37634992
12.
Anti-inflammatory hybrids of secondary amines and amide-sulfamide derivatives.
Eur J Med Chem
; 150: 195-205, 2018 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29529500
13.
Silencing of CXCR4 blocks breast cancer metastasis.
Cancer Res
; 65(3): 967-71, 2005 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15705897
14.
Novel anti-inflammatory agents targeting CXCR4: Design, synthesis, biological evaluation and preliminary pharmacokinetic study.
Eur J Med Chem
; 136: 360-371, 2017 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28521261
15.
Development of CXCR4 modulators by virtual HTS of a novel amide-sulfamide compound library.
Eur J Med Chem
; 126: 464-475, 2017 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27914361
16.
Combination of an Integrin-Targeting NIR Tracer and an Ultrasensitive Spectroscopic Device for Intraoperative Detection of Head and Neck Tumor Margins and Metastatic Lymph Nodes.
Tomography
; 2(3): 215-222, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27738656
17.
Symmetrical bis-tertiary amines as novel CXCR4 inhibitors.
Eur J Med Chem
; 118: 340-50, 2016 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27179215
18.
Benzenesulfonamides: a unique class of chemokine receptor type 4 inhibitors.
ChemMedChem
; 8(4): 622-32, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23468189
19.
Monocarbonyl curcumin analogues: heterocyclic pleiotropic kinase inhibitors that mediate anticancer properties.
J Med Chem
; 56(9): 3456-66, 2013 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-23550937
20.
Inhibition of the CXCL12/CXCR4-axis as preventive therapy for radiation-induced pulmonary fibrosis.
PLoS One
; 8(11): e79768, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24244561